Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayard R Huck

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 17, 2017
Recent progress towards clinically relevant ATP-competitive Akt inhibitorsBayard R Huck, Igor Mochalkin
The Journal of Organic Chemistry|April 23, 2005
Synthesis of 2,2-disubstituted pyrrolidine-4-carboxylic acid derivatives and their incorporation into beta-peptide oligomersBayard R Huck, Samuel H Gellman
Angewandte Chemie (International Ed. in English)|October 4, 2017
Small Molecules Drive Big Improvements in Immuno-Oncology TherapiesBayard R Huck, Lisa Kötzner, Klaus Urbahns
Nature Reviews. Chemistry|April 28, 2023
Rules were made to be brokenIngo V Hartung, Bayard R Huck, Alejandro Crespo
Biochemistry|October 16, 2002
Design of non-cysteine-containing antimicrobial beta-hairpins: structure-activity relationship studies with linear protegrin-1 analoguesJonathan R Lai, Bayard R Huck, Bernard Weisblum, et al.
Protein Science : a Publication of the Protein Society|December 15, 2012
Protein prosthesis: β-peptides as reverse-turn surrogatesUlrich Arnold, Bayard R Huck, Samuel H Gellman, et al.
Journal of the American Chemical Society|September 17, 2004
Secondary structural preferences of 2,2-disubstituted pyrrolidine-4-carboxylic acid oligomers: beta-peptide foldamers that cannot form internal hydrogen bondsBayard R Huck, John D Fisk, Ilia A Guzei, et al.
American Journal of Cancer Research|May 18, 2016
M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrierAndreas Machl, Erik W Wilker, Hui Tian, et al.
Journal of the American Chemical Society|July 18, 2002
Protein prosthesis: a semisynthetic enzyme with a beta-peptide reverse turnUlrich Arnold, Matthew P Hinderaker, Bradley L Nilsson, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2006
The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonistsBayard R Huck, Luis Llamas, Michael J Robarge, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|May 17, 2017
Recent progress towards clinically relevant ATP-competitive Akt inhibitorsBayard R Huck, Igor Mochalkin
The Journal of Organic Chemistry|April 23, 2005
Synthesis of 2,2-disubstituted pyrrolidine-4-carboxylic acid derivatives and their incorporation into beta-peptide oligomersBayard R Huck, Samuel H Gellman
Angewandte Chemie (International Ed. in English)|October 4, 2017
Small Molecules Drive Big Improvements in Immuno-Oncology TherapiesBayard R Huck, Lisa Kötzner, Klaus Urbahns
Nature Reviews. Chemistry|April 28, 2023
Rules were made to be brokenIngo V Hartung, Bayard R Huck, Alejandro Crespo
Biochemistry|October 16, 2002
Design of non-cysteine-containing antimicrobial beta-hairpins: structure-activity relationship studies with linear protegrin-1 analoguesJonathan R Lai, Bayard R Huck, Bernard Weisblum, et al.
Protein Science : a Publication of the Protein Society|December 15, 2012
Protein prosthesis: β-peptides as reverse-turn surrogatesUlrich Arnold, Bayard R Huck, Samuel H Gellman, et al.
Journal of the American Chemical Society|September 17, 2004
Secondary structural preferences of 2,2-disubstituted pyrrolidine-4-carboxylic acid oligomers: beta-peptide foldamers that cannot form internal hydrogen bondsBayard R Huck, John D Fisk, Ilia A Guzei, et al.
American Journal of Cancer Research|May 18, 2016
M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrierAndreas Machl, Erik W Wilker, Hui Tian, et al.
Journal of the American Chemical Society|July 18, 2002
Protein prosthesis: a semisynthetic enzyme with a beta-peptide reverse turnUlrich Arnold, Matthew P Hinderaker, Bradley L Nilsson, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2006
The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonistsBayard R Huck, Luis Llamas, Michael J Robarge, et al.
Pageof 2